The Indonesian health insurance industry is at a crossroads in 2026. Although public awareness of the importance of health protection continues to rise, a massive surge in claims has become a serious burden on the business sustainability of insurance companies.
The latest report from IFG Progress for Q1/2026 highlights a worrying situation, where the claim ratio or loss ratio of individual health insurance has jumped drastically to 184.8%. This figure reflects a situation where for every IDR 100 of premiums received, companies must pay out up to IDR 185 in claim costs, not including other operational and marketing expenses.
There are four main factors driving this rising trend in claims. First, a drastic post-pandemic increase in healthcare service utilization. Second, high medical inflation in Indonesia reaching 16.9%, one of the highest in Asia. Third, a shift in the pattern of chronic diseases such as cancer and heart disease that require long-term treatment costs. Fourth, indications of moral hazard or the excessive use of medical services.
As a mitigation measure, industry players are now starting to implement more selective product pricing adjustments or repricing. However, this step remains under the strict supervision of the Financial Services Authority (OJK) through POJK Number 36/2025, which limits price increases to a maximum of once a year to protect consumer rights.
Looking ahead, the health insurance business strategy is predicted to undergo a major transformation. The industry's focus is now shifting from merely chasing premium growth to cost control through technology, such as using artificial intelligence (AI) for fraud detection, and strengthening collaboration with healthcare providers through managed care mechanisms.
The success of insurance companies in navigating this crisis will highly depend on their ability to balance customer protection with the fundamental health of their business. Without a coordinated response between regulators and market players, the threat of a crisis in the commercial health insurance sector in the Asian region is no longer just a possibility, but a real risk in the coming years.
